Patient-delivered partner therapy in the UK: what do the professionals think?
The aim of this study was to investigate consultant genitourinary (GU) physicians' and health advisers' views regarding acceptability of patient-delivered partner therapy (PDPT) in the United Kingdom (UK). A postal questionnaire was sent to all consultant GU physicians and senior health advisers: 206 (65%) physician questionnaires and 153 (77%) health-adviser questionnaires were returned. One hundred and three (50%) physicians and 31 (22%) health advisers reported ever having used PDPT. Approximately one-third of professionals are strongly opposed to PDPT. However, the majority of both professional groups are cautiously prepared to consider PDPT, but only if there is no other option and only if a health professional first makes contact with the partner. Chief concern among health professionals is the legal status of PDPT in the UK. Here, the current General Medical Council (GMC) guidance on remote prescribing is helpful. The outcome of the Medical Research Council randomized controlled trial on accelerated partner therapy, which fits in with GMC guidance, is eagerly awaited as professionals would welcome evidence-based national guidance.
Department of Genitourinary Medicine, Derriford Hospital, Plymouth PL6 8DH, UK. Sivapatham.Shivasankar@phnt.swest.nhs.uk
Sivapatham
S
Shivasankar
Rachel
R
Challenor
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D016358:Contact Tracing; D005260:Female; D006801:Humans; D008297:Male; D010820:Physicians / Q000523:psychology*; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D011795:Surveys and Questionnaires; D006113:United Kingdom
D000890:Anti-Infective Agents